Finance

Lists
Why is SXTC down 3,68%?
Dive Deeper
SXTC:NASDAQ
China SXT Pharmaceuticals Inc
2,88 $
-3,68%
(-0,11) 1D
17 қар., 09:53:30 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SXTC...
Open
2,84 $
High
2,90 $
Low
2,82 $
Mkt. cap
1,98 млн
Avg. vol.
489,21 м.
Volume
17,71 мың
52-wk high
8 375 824,00 $
52-wk low
2,71 $
EPS
-73 038,80 $
Beta
2,02
Shares outstanding
687,00 м.
No. of employees
56
Open
2,84 $
High
2,90 $
Low
2,82 $
Mkt. cap
1,98 млн
Avg. vol.
489,21 м.
Volume
17,71 мың
52-wk high
8 375 824,00 $
52-wk low
2,71 $
EPS
-73 038,80 $
Beta
2,02
Shares outstanding
687,00 м.
No. of employees
56
News stories
From web sources and news partners
About China SXT Pharmaceuticals Inc
CEO-
Employees56
Founded2005
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
313,28 м.
313,28 м.
255,74 м.
255,74 м.
Cost of goods sold
262,42 м.
262,42 м.
182,25 м.
182,25 м.
Cost of revenue
262,42 м.
262,42 м.
182,25 м.
182,25 м.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,22 млн
3,22 млн
465,50 м.
465,50 м.
Operating expense
3,22 млн
3,22 млн
465,50 м.
465,50 м.
Total operating expenses
3,48 млн
3,48 млн
647,75 м.
647,75 м.
Operating income
-3,17 млн
-3,17 млн
-392,00 м.
-392,00 м.
Other non operating income
724,00
724,00
489,68 м.
489,68 м.
EBT including unusual items
-3,18 млн
-3,18 млн
81,86 мың
81,86 мың
EBT excluding unusual items
-3,18 млн
-3,18 млн
81,86 мың
81,86 мың
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,18 млн
-3,18 млн
81,86 мың
81,86 мың
Net profit margin
-1 016,45%
-1 016,45%
32,01%
32,01%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-15,66 мың
-15,66 мың
-15,82 мың
-15,82 мың
Net interest expenses
-15,66 мың
-15,66 мың
-15,82 мың
-15,82 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,15 млн
-3,15 млн
-371,22 м.
-371,22 м.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары